Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimu (V5) (IMM05)

Clinical Trial ID NCT02232490

PubWeight™ 2.50‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02232490

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Immunotherapy for hepatocellular carcinoma: From basic research to clinical use. World J Hepatol 2015 0.88
2 Immune-based Therapy Clinical Trials in Hepatocellular Carcinoma. J Clin Cell Immunol 2015 0.84
3 Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions. J Int AIDS Soc 2015 0.78
Next 100